vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $30.9M, roughly 1.3× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 46.6% vs -17.2%, a 63.9% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 5.6%). Community Healthcare Trust Inc produced more free cash flow last quarter ($35.9M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 2.7%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

CHCT vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
1.3× larger
STIM
$41.8M
$30.9M
CHCT
Growing faster (revenue YoY)
STIM
STIM
+80.1% gap
STIM
85.7%
5.6%
CHCT
Higher net margin
CHCT
CHCT
63.9% more per $
CHCT
46.6%
-17.2%
STIM
More free cash flow
CHCT
CHCT
$35.2M more FCF
CHCT
$35.9M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
2.7%
CHCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CHCT
CHCT
STIM
STIM
Revenue
$30.9M
$41.8M
Net Profit
$14.4M
$-7.2M
Gross Margin
52.0%
Operating Margin
-12.1%
Net Margin
46.6%
-17.2%
Revenue YoY
5.6%
85.7%
Net Profit YoY
687.6%
43.2%
EPS (diluted)
$0.52
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
STIM
STIM
Q4 25
$30.9M
$41.8M
Q3 25
$31.1M
$37.3M
Q2 25
$29.1M
$38.1M
Q1 25
$30.1M
$32.0M
Q4 24
$29.3M
$22.5M
Q3 24
$29.6M
$18.5M
Q2 24
$27.5M
$16.4M
Q1 24
$29.3M
$17.4M
Net Profit
CHCT
CHCT
STIM
STIM
Q4 25
$14.4M
$-7.2M
Q3 25
$1.6M
$-9.0M
Q2 25
$-12.6M
$-10.1M
Q1 25
$1.6M
$-12.7M
Q4 24
$1.8M
$-12.7M
Q3 24
$1.7M
$-13.3M
Q2 24
$-10.4M
$-9.8M
Q1 24
$3.7M
$-7.9M
Gross Margin
CHCT
CHCT
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
CHCT
CHCT
STIM
STIM
Q4 25
-12.1%
Q3 25
-19.6%
Q2 25
-21.1%
Q1 25
-34.4%
Q4 24
-51.0%
Q3 24
-41.7%
Q2 24
-51.7%
Q1 24
-39.4%
Net Margin
CHCT
CHCT
STIM
STIM
Q4 25
46.6%
-17.2%
Q3 25
5.3%
-24.3%
Q2 25
-43.2%
-26.6%
Q1 25
5.3%
-39.6%
Q4 24
6.3%
-56.4%
Q3 24
5.9%
-72.0%
Q2 24
-37.9%
-59.8%
Q1 24
12.5%
-45.2%
EPS (diluted)
CHCT
CHCT
STIM
STIM
Q4 25
$0.52
$-0.10
Q3 25
$0.03
$-0.13
Q2 25
$-0.50
$-0.15
Q1 25
$0.03
$-0.21
Q4 24
$0.04
$-0.34
Q3 24
$0.04
$-0.44
Q2 24
$-0.42
$-0.33
Q1 24
$0.11
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$3.3M
$28.1M
Total DebtLower is stronger
$532.2M
$65.8M
Stockholders' EquityBook value
$429.4M
$22.4M
Total Assets
$990.8M
$141.6M
Debt / EquityLower = less leverage
1.24×
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
STIM
STIM
Q4 25
$3.3M
$28.1M
Q3 25
$3.4M
$28.0M
Q2 25
$4.9M
$11.0M
Q1 25
$2.3M
$20.2M
Q4 24
$4.4M
$18.5M
Q3 24
$2.8M
$20.9M
Q2 24
$734.0K
$42.6M
Q1 24
$3.8M
$47.7M
Total Debt
CHCT
CHCT
STIM
STIM
Q4 25
$532.2M
$65.8M
Q3 25
$530.1M
$65.7M
Q2 25
$500.1M
$55.5M
Q1 25
$496.0M
$55.3M
Q4 24
$486.0M
$55.2M
Q3 24
$473.7M
$46.0M
Q2 24
$457.6M
$59.8M
Q1 24
$442.3M
$59.4M
Stockholders' Equity
CHCT
CHCT
STIM
STIM
Q4 25
$429.4M
$22.4M
Q3 25
$426.8M
$27.4M
Q2 25
$437.8M
$27.1M
Q1 25
$461.3M
$35.5M
Q4 24
$476.0M
$27.7M
Q3 24
$477.2M
$9.4M
Q2 24
$497.8M
$19.4M
Q1 24
$511.6M
$27.7M
Total Assets
CHCT
CHCT
STIM
STIM
Q4 25
$990.8M
$141.6M
Q3 25
$987.3M
$145.5M
Q2 25
$966.3M
$134.7M
Q1 25
$985.1M
$142.0M
Q4 24
$992.6M
$140.9M
Q3 24
$981.8M
Q2 24
$983.2M
$96.8M
Q1 24
$982.7M
$103.8M
Debt / Equity
CHCT
CHCT
STIM
STIM
Q4 25
1.24×
2.94×
Q3 25
1.24×
2.40×
Q2 25
1.14×
2.05×
Q1 25
1.08×
1.56×
Q4 24
1.02×
1.99×
Q3 24
0.99×
4.90×
Q2 24
0.92×
3.08×
Q1 24
0.86×
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
STIM
STIM
Operating Cash FlowLast quarter
$56.4M
$908.0K
Free Cash FlowOCF − Capex
$35.9M
$692.0K
FCF MarginFCF / Revenue
116.0%
1.7%
Capex IntensityCapex / Revenue
66.3%
0.5%
Cash ConversionOCF / Net Profit
3.91×
TTM Free Cash FlowTrailing 4 quarters
$62.8M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
STIM
STIM
Q4 25
$56.4M
$908.0K
Q3 25
$12.7M
$-785.0K
Q2 25
$13.8M
$-3.5M
Q1 25
$14.4M
$-17.0M
Q4 24
$58.9M
$-8.6M
Q3 24
$13.8M
$-5.4M
Q2 24
$16.7M
$-5.0M
Q1 24
$12.6M
$-12.0M
Free Cash Flow
CHCT
CHCT
STIM
STIM
Q4 25
$35.9M
$692.0K
Q3 25
$7.6M
$-899.0K
Q2 25
$9.6M
$-3.8M
Q1 25
$9.7M
$-17.2M
Q4 24
$34.2M
$-8.7M
Q3 24
$6.7M
$-5.8M
Q2 24
$9.5M
$-5.6M
Q1 24
$7.5M
$-12.4M
FCF Margin
CHCT
CHCT
STIM
STIM
Q4 25
116.0%
1.7%
Q3 25
24.6%
-2.4%
Q2 25
32.9%
-9.9%
Q1 25
32.3%
-53.8%
Q4 24
116.9%
-38.6%
Q3 24
22.5%
-31.3%
Q2 24
34.7%
-34.0%
Q1 24
25.7%
-71.1%
Capex Intensity
CHCT
CHCT
STIM
STIM
Q4 25
66.3%
0.5%
Q3 25
16.3%
0.3%
Q2 25
14.5%
0.7%
Q1 25
15.6%
0.7%
Q4 24
84.1%
0.4%
Q3 24
24.2%
2.1%
Q2 24
26.1%
3.7%
Q1 24
17.4%
2.2%
Cash Conversion
CHCT
CHCT
STIM
STIM
Q4 25
3.91×
Q3 25
7.76×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24
Q1 24
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons